An observational study in Dry Eye, sponsored by Neuro-Ophthalmology of Texas. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-05.
Sponsored by Neuro-Ophthalmology of Texas · Observational
patients from a Neuro Ophthalmology who have dry eye, some of which have neurotrophic keratitis are being analyzed after treatment with Vevye
1,292 studies on the registry are indexed under Dry Eye Syndromes; 191 are open to participants now.
This study's planned enrollment of 50 is below the median of 90 across 171 observational studies indexed under Dry Eye Syndromes.
Browse Dry Eye Syndromes studies →This is the only study on the registry with Neuro-Ophthalmology of Texas as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Dry Eye Disease in a Neuro Ophthalmology clinic
Exclusion Criteria:
Other: Cyclosporine ophthalmic solution 0.1%
Other: Cyclosporine ophthalmic solution 0.1%
one drop in both eyes twice a day
Also known as: Vevye
Corneal fluorescein staining
pre vs post treatment
Time frame: Baseline compared to week 4
Plan to share: Yes — results of pre and post treatment data
Supporting information: Sap
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.